Retinal tissue has been regrown in three patients with age-related macular degeneration (AMD) with geographic atrophy or dry (atrophic) AMD in a Phase I/IIa study conducted by Lineage Cell Therapeutics. “This has the potential to offer a whole new paradigm to treat the disease,” Brian Culley, CEO of Lineage, told BioSpace.
Continue reading...
No comments:
Post a Comment